FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065863629> ?p ?o ?g. }

• W2065863629 endingPage "1257" @default.
• W2065863629 startingPage "1250" @default.
• W2065863629 abstract "Vascular endothelial growth factor-A is widely regarded as the principal stimulator of angiogenesis required for tumour growth. VEGF is generated as multiple isoforms of two families, the pro-angiogenic family generated by proximal splice site selection in the terminal exon, termed VEGFxxx, and the anti-angiogenic family formed by distal splice site selection in the terminal exon, termed VEGFxxxb, where xxx is the amino acid number. The most studied isoforms, VEGF165 and VEGF165b have been shown to be present in tumour and normal tissues respectively. VEGF165b has been shown to inhibit VEGF- and hypoxia-induced angiogenesis, and VEGF-induced cell migration and proliferation in vitro. Here we show that overexpression of VEGF165b by tumour cells inhibits the growth of prostate carcinoma, Ewing's sarcoma and renal cell carcinoma in xenografted mouse tumour models. Moreover, VEGF165b overexpression inhibited tumour cell-mediated migration and proliferation of endothelial cells. These data show that overexpression of VEGF165b can inhibit growth of multiple tumour types in vivo indicating that VEGF165b has potential as an anti-angiogenic, anti-tumour strategy in a number of different tumour types, either by control of VEGF165b expression by regulation of splicing, overexpression of VEGF165b, or therapeutic delivery of VEGF165b to tumours." @default.
• W2065863629 created "2016-06-24" @default.
• W2065863629 creator A5005127609 @default.
• W2065863629 creator A5010429410 @default.
• W2065863629 creator A5019822912 @default.
• W2065863629 creator A5022667959 @default.
• W2065863629 creator A5023058464 @default.
• W2065863629 creator A5029607573 @default.
• W2065863629 creator A5030030187 @default.
• W2065863629 creator A5069036413 @default.
• W2065863629 creator A5071134086 @default.
• W2065863629 creator A5076453623 @default.
• W2065863629 creator A5086609521 @default.
• W2065863629 date "2008-03-18" @default.
• W2065863629 modified "2023-10-14" @default.
• W2065863629 title "The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice" @default.
• W2065863629 cites W1802218256 @default.
• W2065863629 cites W2000185616 @default.
• W2065863629 cites W2007087942 @default.
• W2065863629 cites W2013038209 @default.
• W2065863629 cites W2014604539 @default.
• W2065863629 cites W2015344488 @default.
• W2065863629 cites W2028952750 @default.
• W2065863629 cites W2067755082 @default.
• W2065863629 cites W2077129920 @default.
• W2065863629 cites W2086302495 @default.
• W2065863629 cites W2094803864 @default.
• W2065863629 cites W2128012941 @default.
• W2065863629 cites W2130340433 @default.
• W2065863629 cites W2147641095 @default.
• W2065863629 cites W2152561045 @default.
• W2065863629 cites W2153496962 @default.
• W2065863629 cites W2157769714 @default.
• W2065863629 cites W2159918536 @default.
• W2065863629 cites W2164971856 @default.
• W2065863629 cites W4235333461 @default.
• W2065863629 cites W4294216491 @default.
• W2065863629 doi "https://doi.org/10.1038/sj.bjc.6604309" @default.
• W2065863629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2359649" @default.
• W2065863629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18349828" @default.
• W2065863629 hasPublicationYear "2008" @default.
• W2065863629 type Work @default.
• W2065863629 sameAs 2065863629 @default.
• W2065863629 citedByCount "116" @default.
• W2065863629 countsByYear W20658636292012 @default.
• W2065863629 countsByYear W20658636292013 @default.
• W2065863629 countsByYear W20658636292014 @default.
• W2065863629 countsByYear W20658636292015 @default.
• W2065863629 countsByYear W20658636292016 @default.
• W2065863629 countsByYear W20658636292017 @default.
• W2065863629 countsByYear W20658636292018 @default.
• W2065863629 countsByYear W20658636292019 @default.
• W2065863629 countsByYear W20658636292020 @default.
• W2065863629 countsByYear W20658636292021 @default.
• W2065863629 countsByYear W20658636292022 @default.
• W2065863629 countsByYear W20658636292023 @default.
• W2065863629 crossrefType "journal-article" @default.
• W2065863629 hasAuthorship W2065863629A5005127609 @default.
• W2065863629 hasAuthorship W2065863629A5010429410 @default.
• W2065863629 hasAuthorship W2065863629A5019822912 @default.
• W2065863629 hasAuthorship W2065863629A5022667959 @default.
• W2065863629 hasAuthorship W2065863629A5023058464 @default.
• W2065863629 hasAuthorship W2065863629A5029607573 @default.
• W2065863629 hasAuthorship W2065863629A5030030187 @default.
• W2065863629 hasAuthorship W2065863629A5069036413 @default.
• W2065863629 hasAuthorship W2065863629A5071134086 @default.
• W2065863629 hasAuthorship W2065863629A5076453623 @default.
• W2065863629 hasAuthorship W2065863629A5086609521 @default.
• W2065863629 hasBestOaLocation W20658636291 @default.
• W2065863629 hasConcept C104317684 @default.
• W2065863629 hasConcept C146285616 @default.
• W2065863629 hasConcept C167734588 @default.
• W2065863629 hasConcept C194583182 @default.
• W2065863629 hasConcept C2777025900 @default.
• W2065863629 hasConcept C2780394083 @default.
• W2065863629 hasConcept C36823959 @default.
• W2065863629 hasConcept C502942594 @default.
• W2065863629 hasConcept C53345823 @default.
• W2065863629 hasConcept C54355233 @default.
• W2065863629 hasConcept C62112901 @default.
• W2065863629 hasConcept C86803240 @default.
• W2065863629 hasConceptScore W2065863629C104317684 @default.
• W2065863629 hasConceptScore W2065863629C146285616 @default.
• W2065863629 hasConceptScore W2065863629C167734588 @default.
• W2065863629 hasConceptScore W2065863629C194583182 @default.
• W2065863629 hasConceptScore W2065863629C2777025900 @default.
• W2065863629 hasConceptScore W2065863629C2780394083 @default.
• W2065863629 hasConceptScore W2065863629C36823959 @default.
• W2065863629 hasConceptScore W2065863629C502942594 @default.
• W2065863629 hasConceptScore W2065863629C53345823 @default.
• W2065863629 hasConceptScore W2065863629C54355233 @default.
• W2065863629 hasConceptScore W2065863629C62112901 @default.
• W2065863629 hasConceptScore W2065863629C86803240 @default.
• W2065863629 hasIssue "7" @default.
• W2065863629 hasLocation W20658636291 @default.
• W2065863629 hasLocation W20658636292 @default.
• W2065863629 hasLocation W20658636293 @default.
• W2065863629 hasLocation W20658636294 @default.

• next